Health Highlights, Nov. 1, 2021
FDA delays decision on Moderna vaccine for teens under 17: The company announced Sunday that the agency said it needs more time to examine data on a rare cardiac side effect seen in young males after Moderna's second shot, with any approval likely pushed back to January 2022. Read more
A new way to predict risk of premature birth? A two-minute test can accurately detect vaginal bacteria associated with preterm birth, researchers discovered. Read more
Nurses bear brunt of patient aggression far too often. Nurses caring for COVID-19 patients are more than twice as likely to be physically attacked or verbally abused as those caring for other patients, and some share their stories with HealthDay Now. Read more
A breathalyzer test for COVID-19? It can detect COVID-19 within seconds and could become a noninvasive, faster alternative to nasal swab tests, researchers report. Read more
5 million dead from COVID-19 worldwide. Less than two years into the pandemic, even countries with first-rate health systems have been humbled by the new coronavirus. The United States alone has recorded over 740,000 lives lost, more than any other nation. Read more
Related Posts
Barrios más pobres vinculados a tasas más elevadas de asma en niños
VIERNES, 1 de septiembre de 2023 (HealthDay News) -- Cuando se considera por...
PCP-Specialist Cotraining Improves Patient Experiences
TUESDAY, Jan. 3, 2023 (HealthDay News) -- Primary care physician...
Un grupo de pediatras insta a administrar la nueva inyección contra el VSR a todos los bebés
MIÉRCOLES, 16 de agosto de 2023 (HealthDay News) -- Todos los bebés deben...
Moderna Asks FDA to Approve Its Booster Shot for All Adults
THURSDAY, Nov. 18, 2021 (HealthDay News) -- Moderna asked the U.S. Food and Drug...